W.R. Huff Asset Management’s Pfizer PFE Stock Holding History

W.R. Huff Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$292K	Hold	9,486	–	–	0.25%	41
2016 Q3	$305K	Hold	9,486	–	–	0.24%	41
2016 Q2	$317K	Hold	9,486	–	–	0.27%	38
2016 Q1	$267K	Hold	9,486	–	–	0.25%	39
2015 Q4	$291K	Hold	9,486	–	–	0.26%	39
2015 Q3	$283K	Hold	9,486	–	–	0.26%	36
2015 Q2	$302K	Hold	9,486	–	–	0.24%	40
2015 Q1	$313K	Hold	9,486	–	–	0.27%	39
2014 Q4	$280K	Buy	+9,486	New	+$272K	0.22%	38

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

W.R. Huff Asset Management's PFE Position: Q4 2016 in Review

W.R. Huff Asset Management held its Pfizer (PFE) position steady in Q4 2016 at 9,486 shares worth $292K. The position accounts for 0.25% of the portfolio, ranked #41.

W.R. Huff Asset Management first reported a position in PFE in Q4 2014 and has held it in 9 quarters since. The position peaked at $317K in Q2 2016. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

W.R. Huff Asset Management held 9,486 shares of Pfizer worth $292K as of Q4 2016.
W.R. Huff Asset Management left its Pfizer share count unchanged in Q4 2016.
Pfizer made up 0.25% of W.R. Huff Asset Management's portfolio in Q4 2016, its #41 holding.
W.R. Huff Asset Management first reported a position in Pfizer in Q4 2014 and has held it in 9 quarters since.
W.R. Huff Asset Management's Pfizer position peaked at $317K in Q2 2016.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on W.R. Huff Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.